1. |
Nakeeb A, Comuzzie AG, Martin L, et al. Gallstones: genetics versus environment [J]. Ann Surg, 2002; 235(6): 842849.
|
2. |
Wang HH, Portincasa P, MendezSanchez N, et al. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones [J]. Gastroenterology, 2008; 134(7): 21012110.
|
3. |
冯怡燕, 李海. 基因多态性参与胆固醇结石发病机制的研究进展 [J]. 国际消化杂志, 2008; 29(3): 157159.
|
4. |
李燕, 凌文华. 胆固醇和脂肪酸对CYP7A1的调节 [J]. 国外医学内科学分册, 2004; 31(1): 14.
|
5. |
Kouji K, Margaret E, Brousseau, et al. A promoter polymorphism in cholesterol 7αhydroxylase interacts with apolipoprotein E genotype in the LDLlowering response to atorvastatin [J]. Atherosclerosis, 2005; 180(3): 407415.
|
6. |
Barcelos AL, Chies R, Almeida SE, et al. Association of CYP7A1278A>C polymorphism and the response of plasma triglyceride after dietary intervention in dyslipidemic patients [J]. Braz J Med Biol Res, 2009; 42(6): 487493.
|
7. |
Chan J, Donalson LM, Kushwaha RS, et al. Differential expression of hepatic genes involved in cholesterol homeostasis in high and lowresponding strains of laboratory opossums [J]. Metabolism, 2008; 57(5): 718724.
|
8. |
Srivastava A, Pandey SN, Choudhuri G, et al. Role of genetic variant A204C of cholesterol 7αhydroxylase (CYP7A1) in susceptibility to gallbladder cancer [J]. Mol Genet Metab, 2008; 94(1): 8389.
|
9. |
Lambrinoudaki IV, Kaparos GI, Vlachou SA, et al. CYP A204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women [J]. Menopause, 2008; 15(6): 11631168.
|
10. |
周斌, 张思仲, 肖翠英, 等. 胆固醇7α羟化酶基因A204C单核苷酸多态性及其与血浆血脂的关联 [J]. 遗传, 2004; 26(3): 283286.
|
11. |
陆志强, 高鑫, 胡予, 等. 中国上海人群中胆固醇7α羟化酶基因多态性与高低密度脂蛋白胆固醇血症的关系研究 [J]. 中国临床医学, 2001; 8(4): 378379.
|
12. |
Couture P, Otvos JD, Cupples LA, et al. Association of the A204C polymorphism in the cholesterol 7αhydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study [J]. J Lipid Res, 1999; 40(10): 18831889.
|
13. |
Jiang ZY, Jiang CY, Wang L, et al. Increased NPCIL1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients [J]. Biochem Biophys Res Commun, 2009; 379(1): 4954.
|
14. |
Juzyszyn Z, Kurzawski M, Modrzejewski A, et al. Lowdensity lipoprotein receptorrelated protein associated protein (LRPAP1) gene IVS5 insertion/deletion polymorphism is not a risk factor for gallstone disease in a Polish population [J]. Dig Liver Dis, 2008; 40(2): 122125.
|
15. |
Hwang ES. Cholesterol gallstone formation in hypercholesterolemia [J]. Arch Pharm Res, 2009; 32(9): 11771178.
|
16. |
Wang HH, Liu M, Clegg DJ, et al. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation [J]. Biochim Biophys Acta, 2009; 1791(11): 10371047.
|
17. |
韩天权, 蒋兆彦, 张圣道. 胆固醇结石形成机制的基因研究现状与展望 [J]. 外科理论与实践, 2009; 14(2): 125127.
|
18. |
Zanlungo S, Rigotti A. Determinants of transhepatic cholesterol flux and their relevance for gallstone formation [J]. Liver Int, 2009; 29(3): 323330.
|
19. |
姚有贵, 马明坤, 蒲道深, 等. 载脂蛋白AⅠCⅢAⅣ基因簇XmnⅠ、MspⅠ位点多态性与胆固醇结石病关系的研究 [J]. 中国普外基础与临床杂志, 2007; 14(3): 287291.
|
20. |
姚有贵, 马明坤, 何满西, 等. 胆囊胆固醇结石病与载脂蛋白AⅠCⅢAⅣ基因PstⅠ、SstⅠ位点多态性关联的临床实验研究 [J]. 华西医学, 2007; 22(1): 120122.
|
21. |
Kovár J, Suchánek P, Hubácek JA, et al. The A204C polymorphism in the cholesterol 7αhydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a highfat diet [J]. Physiol Res, 2004; 53(5): 565568.
|
22. |
杨士勇, 王建承, 韩天权, 等. 胆固醇结石患者肝脏核受体基因表达的研究 [J]. 中国普外基础与临床杂志, 2008; 15(10): 751755.
|
23. |
Kajinami K, Brousseau ME, Ordovas JM, et al. Interactions between common genetic polymorphisms in ABCG5/G8 and CYP7A1 on LDL cholesterollowering response to atorvastatin [J]. Atherosclerosis, 2004; 175(2): 287293.
|
24. |
Gilardi F, Mitro N, Godio C, et al .The pharmacological exploitation of cholesterol 7αhydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol [J]. Pharmacol Ther, 2007; 116(3): 449472.
|